Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo Controlled Trial of 4-Hydroxytamoxifen Gel for Reducing Breast Tissue Density in Women With BI-RADS Breast Density Categories C or D

NCT03199963 is registered in ClinicalTrials.gov with BHR Pharma, LLC as lead sponsor.

NCT NCT03199963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03199963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo Controlled Trial of 4-Hydroxytamoxifen Gel for Reducing Breast Tissue Density in Women With BI-RADS Breast Density Categories C or D
Lead sponsor
BHR Pharma, LLC
Phase
Phase 3
Overall status
Terminated
Start date
August 21, 2017
Completion date
April 23, 2019
Enrollment
223 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

mammographic breast density